Canada markets closed

Reneo Pharmaceuticals, Inc. (RPHM)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.7400-0.0200 (-1.14%)
At close: 04:00PM EDT
1.7400 0.00 (0.00%)
After hours: 04:03PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 58.15M
Enterprise Value -43.84M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.66
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 0.53

Trading Information

Stock Price History

Beta (5Y Monthly) 0.24
52-Week Change 3-82.02%
S&P500 52-Week Change 320.07%
52 Week High 310.9800
52 Week Low 30.9800
50-Day Moving Average 31.6660
200-Day Moving Average 34.6708

Share Statistics

Avg Vol (3 month) 3220.81k
Avg Vol (10 day) 399.85k
Shares Outstanding 533.42M
Implied Shares Outstanding 633.42M
Float 814.76M
% Held by Insiders 13.00%
% Held by Institutions 182.14%
Shares Short (Mar 28, 2024) 42.92M
Short Ratio (Mar 28, 2024) 417.8
Short % of Float (Mar 28, 2024) 414.55%
Short % of Shares Outstanding (Mar 28, 2024) 48.73%
Shares Short (prior month Feb 29, 2024) 42.59M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-47.77%
Return on Equity (ttm)-82.07%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -82.23M
Net Income Avi to Common (ttm)-77.39M
Diluted EPS (ttm)-2.5200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)102.96M
Total Cash Per Share (mrq)3.08
Total Debt (mrq)973k
Total Debt/Equity (mrq)1.10%
Current Ratio (mrq)5.87
Book Value Per Share (mrq)2.65

Cash Flow Statement

Operating Cash Flow (ttm)-63.68M
Levered Free Cash Flow (ttm)-33.79M